These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6094103

  • 21. Activation of platelets and of fibrinolysis by venous occlusion in healthy volunteers and influence of suloctidil in comparison with placebo.
    Baele G, Bary JL, van Stalle F.
    Arzneimittelforschung; 1983; 33(8):1203-5. PubMed ID: 6315025
    [Abstract] [Full Text] [Related]

  • 22. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G, Scali G, Casa B, Nonis E.
    Clin Ter; 1980 Aug 31; 94(4):427-44. PubMed ID: 6257445
    [No Abstract] [Full Text] [Related]

  • 23. [Suloctidil in the treatment of focal cerebral ischemia].
    Bartko D, Zúzi M, Brezná M, Trávniková M, Porubec V.
    Cesk Neurol Neurochir; 1984 Mar 31; 47(2):103-8. PubMed ID: 6323038
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Therapy of hyperlipidemia. Clinical experience with clinofibrate].
    Avellone G, Di Garbo V, Strano A.
    Clin Ter; 1989 Apr 15; 129(1):25-9. PubMed ID: 2525449
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Evaluation of therapeutic effect of suloctidil in aged patients with cerebrovascular insufficiency. Double-blind study in comparison with placebo].
    Bargheon J.
    Acta Clin Belg; 1977 Apr 15; 32(1):15-21. PubMed ID: 331820
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. No effect of activated charcoal on hyperlipidaemia. A double-blind prospective trial.
    Hoekstra JB, Erkelens DW.
    Neth J Med; 1988 Dec 15; 33(5-6):209-16. PubMed ID: 3065658
    [No Abstract] [Full Text] [Related]

  • 30. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
    Caimi G, Catania A, Frazzetta F, Capobianco D, Francavilla G, Romano A, Sarno A.
    Ric Clin Lab; 1983 Dec 15; 13 Suppl 3():465-8. PubMed ID: 6324326
    [Abstract] [Full Text] [Related]

  • 31. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
    Marongiu G, Dettori G, Gadeddu A, Noya G, Angius P, Biglioli P.
    Minerva Cardioangiol; 1983 Dec 15; 31(7-8):407-10. PubMed ID: 6316206
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial.
    Rabkin SW, Hayden M, Frohlich J.
    Atherosclerosis; 1988 Oct 15; 73(2-3):233-40. PubMed ID: 3056431
    [Abstract] [Full Text] [Related]

  • 33. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
    Armani U, Piana A.
    Arch Maragliano Patol Clin; 1979 Oct 15; 35(2):57-62. PubMed ID: 233645
    [No Abstract] [Full Text] [Related]

  • 34. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
    Prusiński A, Kotwica S, Niewodniczy A, Split W.
    Wiad Lek; 1982 May 01; 35(3-4):201-5. PubMed ID: 6287740
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C, Quadri A, Ratti S, Levi GF, Prandini BD.
    G Ital Cardiol; 1978 May 01; 8(7):743-51. PubMed ID: 355033
    [Abstract] [Full Text] [Related]

  • 37. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
    Davì G, Pinto A, Novo S, Avellone G, Galati D, Mazzola A.
    Clin Ter; 1982 Oct 31; 103(2):131-7. PubMed ID: 6295693
    [No Abstract] [Full Text] [Related]

  • 38. Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias. A controlled double-blind trial.
    Carulli N, Ponz de Leon M, Podda M, Zuin M, Strata A, Frigerio G, Digrisolo A.
    J Clin Pharmacol; 1981 Oct 31; 21(10):436-42. PubMed ID: 7031100
    [Abstract] [Full Text] [Related]

  • 39. Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial.
    Mirmiran P, Fazeli MR, Asghari G, Shafiee A, Azizi F.
    Br J Nutr; 2010 Aug 31; 104(3):402-6. PubMed ID: 20334708
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.